Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients

Nivolumab plus interferon-γ in the treatment of intractable mucormycosis

(2017) David Grimaldi et al.   LANCET INFECTIOUS DISEASES

Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries

(2016) Zoi Dorothea Pana et al.   BMC INFECTIOUS DISEASES

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

(2016) Johan A Maertens et al.   LANCET

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

(2016) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

Role of isavuconazole in the treatment of invasive fungal infections

(2016) Dustin Wilson et al.   Therapeutics and Clinical Risk Management

Azole-resistant aspergillosis

(2015) Adilia Warris   JOURNAL OF INFECTION

Acute Invasive Fungal Rhinosinusitis in Children With Hematologic Malignancies: Outcome of Surgical Treatment

(2015) Arkadi Yakirevitch et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

(2014) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications

(2014) Julie Autmizguine et al.   DRUGS

A Prospective, International Cohort Study of Invasive Mold Infections in Children

(2014) Rachel L. Wattier et al.   Journal of the Pediatric Infectious Diseases Society

Why is mucormycosis more difficult to cure than more common mycoses?

(2013) A. Katragkou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Successful isavuconazole salvage therapy in a patient with invasive mucormycosis

(2013) J. Ervens et al.   INFECTION

Epidemiology and Clinical Manifestations of Mucormycosis

(2012) George Petrikkos et al.   CLINICAL INFECTIOUS DISEASES

Risk Factors of Amphotericin B Toxicty in the Nonneonatal Pediatric Population

(2012) Ankhi Dutta et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Rhino-Orbital-Cerebral Mucormycosis

(2012) Maria N. Gamaletsou et al.   Current Infectious Disease Reports

How I treat mucormycosis

(2011) D. P. Kontoyiannis et al.   BLOOD

Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases

(2011) Jan Däbritz et al.   MYCOSES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Invasive mold infections in iatrogenically immunocompromised children: An eight-yr review

(2008) Abdulkader Al-Rezqi et al.   PEDIATRIC TRANSPLANTATION